Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve unaudited financial results for the period ended September 30, 2026 and other business matters

Nectar Lifesciences Ltd. Ref No. NLL/CS/2026- 747 November 06, 2026 1. National Stock Exchange of India Limited 2. BSE Limited Listing Department, Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, P J Towers, Dalal Street, Bandra (E), Mumbai 400 051 Mumbai 400 001 Symbol: NECLIFE Scrip Code: 532649 Sub: Notice of Board Meeting Dear Sir/ Madam, Pursuant to Regulations 29, 30, 33 and other applicable Regulations of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that a meeting of the Board of Directors of the company will be held on Saturday, November 14, 2026, to consider and approve, inter alia amongst other items, the Unaudited Financial Results for the quarter ended on September 30, 2026, and matters related thereto. This is for your information and record please. Thanking you, Yours faithfully, For Nectar Lifesciences Limited (Sanjaymohan Singh Rawat) Company Secretary & Compliance Officer Corporate Office: Godrej Eternia, Plot No. 70, Industrial Area, Phase 1, Chandigarh 160 002, INDIA Registered Office: Showroom no. 8, First Floor, Patiala Complex, Barwala Road, Dera Bassi, Distt. S.A.S Nagar, Punjab- 140 507, INDIA Website: www.neclife.com, E-mail: nectar.info@neclife.com CIN: L21000PB1995PLC016664